The American Diabetes Association And DaVita Announce Expansion Of A Multi-Year Collaboration, Focused On Advancing Chronic Disease Prevention, Specifically Addressing Diabetes And Chronic Kidney Disease
Portfolio Pulse from Benzinga Newsdesk
The American Diabetes Association (ADA) and DaVita (NYSE:DVA) have expanded their multi-year collaboration to advance chronic disease prevention, focusing on diabetes and chronic kidney disease (CKD). This expansion, announced during National Kidney Month, includes a $1.5 million contribution from DaVita to the ADA's initiatives. The partnership aims to increase awareness, education, and support, especially in communities of color disproportionately affected by these conditions. Efforts include creating educational materials, a dietitian program, and sponsoring ADA's State of Diabetes events.
March 11, 2024 | 8:44 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
DaVita has expanded its collaboration with the ADA, contributing $1.5 million to advance chronic disease prevention, focusing on diabetes and CKD. This partnership aims to enhance education and support, particularly in high-need communities.
DaVita's expanded partnership and financial contribution to the ADA highlight its commitment to chronic disease prevention and community health, potentially improving its public image and stakeholder trust. This could positively influence investor sentiment and stock performance in the short term, especially given the focus on high-need communities and health equity.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90